Search Results for: Influenza

856 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
DMD and SNTG1 dystrophin syntrophin gamma 1
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DMD and HAUS1 dystrophin HAUS augmin like complex subunit 1
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • AURKA Activation by TPX2
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DMD and SNTG2 dystrophin syntrophin gamma 2
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DMD and CADPS2 dystrophin calcium dependent secretion activator 2
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Calcium Citrate
  • Calcium Phosphate
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DMD and HNF4A dystrophin hepatocyte nuclear factor 4 alpha
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Nuclear Receptor transcription pathway
  • Lauric Acid
  • AVI-4557
  • Myristic acid
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
  • Maturity onset diabetes of the young (MODY)
DMD and SNTA1 dystrophin syntrophin alpha 1
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DMD and SNTB1 dystrophin syntrophin beta 1
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DMD and SNTB2 dystrophin syntrophin beta 2
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DMD and MAP3K5 dystrophin mitogen-activated protein kinase kinase kinase 5
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • Oxidative Stress Induced Senescence
  • Oxidative Stress Induced Senescence
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DMD and UTRN dystrophin utrophin
  • Non-integrin membrane-ECM interactions
  • Striated Muscle Contraction
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Zinc
  • Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
  • Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
  • Dilated cardiomyopathy (DCM)
DNMT1 and L3MBTL3 DNA methyltransferase 1 L3MBTL histone methyl-lysine binding protein 3
  • PRC2 methylates histones and DNA
  • NoRC negatively regulates rRNA expression
  • SUMOylation of DNA methylation proteins
  • DNA methylation
  • Azacitidine
  • Procainamide
  • Flucytosine
  • Decitabine
  • Epigallocatechin Gallate
DPT and TGFB1 dermatopontin transforming growth factor beta 1
  • Platelet degranulation
  • Influenza Virus Induced Apoptosis
  • Cell surface interactions at the vascular wall
  • Molecules associated with elastic fibres
  • Downregulation of TGF-beta receptor signaling
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Syndecan interactions
  • ECM proteoglycans
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGFBR1 LBD Mutants in Cancer
  • Transcriptional regulation of white adipocyte differentiation
  • UCH proteinases
  • Interleukin-4 and Interleukin-13 signaling
  • RUNX3 regulates CDKN1A transcription
  • Regulation of RUNX3 expression and activity
  • RUNX3 regulates p14-ARF
  • Hyaluronidase
  • Hyaluronidase (Human Recombinant)
  • Graft-versus-host disease
  • Allograft rejection
  • Camurati-Engelmann disease; Progressive diaphyseal dysplasia
DR1 and DRAP1 down-regulator of transcription 1 DR1 associated protein 1
  • HATs acetylate histones
  • Signaling by NODAL
  • Signaling by Activin
DRD2 and TRPC4 dopamine receptor D2 transient receptor potential cation channel subfamily C member 4
  • Dopamine receptors
  • TRP channels
  • Role of second messengers in netrin-1 signaling
  • Amphetamine
  • Ziprasidone
  • Cabergoline
  • Ropinirole
  • Olanzapine
  • Clozapine
  • Mirtazapine
  • Thiethylperazine
  • Sulpiride
  • Loxapine
  • Remoxipride
  • Pramipexole
  • Promazine
  • Prochlorperazine
  • Droperidol
  • Imipramine
  • Chlorpromazine
  • Buspirone
  • Haloperidol
  • Triflupromazine
  • Nortriptyline
  • Amoxapine
  • Cinnarizine
  • Lisuride
  • Fluphenazine
  • Thioridazine
  • Ergotamine
  • Apomorphine
  • Trimipramine
  • Risperidone
  • Propiomazine
  • Minaprine
  • Trifluoperazine
  • Perphenazine
  • Flupentixol
  • Amantadine
  • Mesoridazine
  • Maprotiline
  • Dopamine
  • Carphenazine
  • Memantine
  • Ergoloid mesylate
  • Acetophenazine
  • Promethazine
  • Pimozide
  • Doxepin
  • Desipramine
  • Domperidone
  • Pergolide
  • Bromocriptine
  • Ketamine
  • Quetiapine
  • Metoclopramide
  • Levodopa
  • Aripiprazole
  • Chlorprothixene
  • Paliperidone
  • Yohimbine
  • Methotrimeprazine
  • Alizapride
  • Rolicyclidine
  • Acepromazine
  • Molindone
  • Pipotiazine
  • Thioproperazine
  • Thiothixene
  • Zuclopenthixol
  • Aniracetam
  • Fluspirilene
  • Tetrabenazine
  • Brasofensine
  • Bifeprunox
  • Bicifadine
  • Itopride
  • Iloperidone
  • Rotigotine
  • Pimavanserin
  • BL-1020
  • ACP-104
  • Cariprazine
  • Lumateperone
  • Sertindole
  • Mianserin
  • Asenapine
  • Amisulpride
  • Lurasidone
  • Perospirone
  • Bromopride
  • Quinagolide
  • Brexpiprazole
  • Etoperidone
  • AS-8112
  • Pardoprunox
  • Tetrahydropalmatine
  • Piribedil
  • Raclopride
  • Tiapride
DRD5 and GABRG2 dopamine receptor D5 gamma-aminobutyric acid type A receptor subunit gamma2
  • Dopamine receptors
  • G alpha (s) signalling events
  • ADORA2B mediated anti-inflammatory cytokines production
  • Signaling by ERBB4
  • GABA receptor activation
  • GABA receptor activation
  • Ziprasidone
  • Cabergoline
  • Cabergoline
  • Ropinirole
  • Olanzapine
  • Olanzapine
  • Mirtazapine
  • Loxapine
  • Loxapine
  • Pramipexole
  • Imipramine
  • Chlorpromazine
  • Chlorpromazine
  • Cinnarizine
  • Lisuride
  • Ergotamine
  • Apomorphine
  • Trimipramine
  • Fenoldopam
  • Dopamine
  • Dopamine
  • Carphenazine
  • Pergolide
  • Bromocriptine
  • Quetiapine
  • Levodopa
  • Aripiprazole
  • Methotrimeprazine
  • Zuclopenthixol
  • Rotigotine
  • Mianserin
  • Quinagolide
  • Lorazepam
  • Ethchlorvynol
  • Enflurane
  • Temazepam
  • Temazepam
  • Butabarbital
  • Butalbital
  • Topiramate
  • Etomidate
  • Talbutal
  • Pentobarbital
  • Olanzapine
  • Clobazam
  • Meprobamate
  • Carisoprodol
  • Eszopiclone
  • Alprazolam
  • Zolpidem
  • Metharbital
  • Chlordiazepoxide
  • Amoxapine
  • Adinazolam
  • Clorazepate
  • Acamprosate
  • Midazolam
  • Flurazepam
  • Isoflurane
  • Primidone
  • Halazepam
  • Halazepam
  • Propofol
  • Diazepam
  • Diazepam
  • Oxazepam
  • Oxazepam
  • Triazolam
  • Triazolam
  • Methoxyflurane
  • Ergoloid mesylate
  • Clonazepam
  • Methyprylon
  • Halothane
  • Desflurane
  • Flumazenil
  • Flumazenil
  • Estazolam
  • Estazolam
  • Sevoflurane
  • Ginkgo biloba
  • Glutethimide
  • Flunitrazepam
  • Bromazepam
  • Clotiazepam
  • Fludiazepam
  • Prazepam
  • Prazepam
  • Quazepam
  • Quazepam
  • Cinolazepam
  • Nitrazepam
  • Prasterone
  • Taurine
  • Adipiplon
  • Stiripentol
  • Etizolam
  • Thiocolchicoside
  • Muscimol
  • Lormetazepam
  • Febrile seizures, including: Febrile convulsions; Generalized epilepsy with febrile seizure plus (GEFS+); Dravet syndrome/ Severe myoclonic epilepsy in infancy (SMEI)
  • Idiopathic generalied epilepsies (IGEs), including: Childhood absence epilepsy (CAE); Juvenile absence epilepsy (JAE); Juvenile myoclonic epilepsy (JME); Epilepsy with generalized tonic-clonic seizures alone
ATN1 and PDCD6IP atrophin 1 programmed cell death 6 interacting protein
  • Regulation of PTEN gene transcription
  • Budding and maturation of HIV virion
  • Uptake and function of anthrax toxins
  • Dentatorubropallidoluysian atrophy (DRPLA)
E2F1 and TFDP1 E2F transcription factor 1 transcription factor Dp-1
  • Activation of NOXA and translocation to mitochondria
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • Activation of PUMA and translocation to mitochondria
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • CDC6 association with the ORC:origin complex
  • G2 Phase
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional Regulation by E2F6
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
  • Activation of NOXA and translocation to mitochondria
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • Activation of PUMA and translocation to mitochondria
  • G0 and Early G1
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional Regulation by E2F6
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
E2F2 and TFDP1 E2F transcription factor 2 transcription factor Dp-1
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • CDC6 association with the ORC:origin complex
  • Cyclin D associated events in G1
  • Activation of NOXA and translocation to mitochondria
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • Activation of PUMA and translocation to mitochondria
  • G0 and Early G1
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional Regulation by E2F6
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
E2F3 and TFDP1 E2F transcription factor 3 transcription factor Dp-1
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • CDC6 association with the ORC:origin complex
  • G2 Phase
  • Cyclin D associated events in G1
  • Activation of NOXA and translocation to mitochondria
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • Activation of PUMA and translocation to mitochondria
  • G0 and Early G1
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional Regulation by E2F6
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
E2F4 and TFDP1 E2F transcription factor 4 transcription factor Dp-1
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • G0 and Early G1
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • Activation of NOXA and translocation to mitochondria
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • Activation of PUMA and translocation to mitochondria
  • G0 and Early G1
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional Regulation by E2F6
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis

Page 19 out of 43 pages